Grégoire Desolneux
Grégoire Desolneux publishes mostly in Surgery, Oncology and Pulmonary and Respiratory Medicine, on topics such as Hepatocellular Carcinoma Treatment and Prognosis, Intraperitoneal and Appendiceal Malignancies and Colorectal Cancer Treatments and Studies.
- World rank
- #2,509,141 of 7,710,434 ranked researchers
- Rank in France
- #107,308 of 324,115
- Works
- 48
- Citations
- 761
- Citations per work
- 15.9
What does Grégoire Desolneux research?
Grégoire Desolneux's work is mostly in Medicine (81%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3981.1%
- Medicine3981.1%
- Everything else918.9%
- 1Surgery28% of their works
- 2Oncology20% of their works
- 3Pulmonary and Respiratory Medicine12% of their works
- 4Hepatology12% of their works
- 5Radiology, Nuclear Medicine and Imaging7% of their works
- 6Epidemiology3% of their works
Research topics
- Hepatocellular Carcinoma Treatment and Prognosis
- Intraperitoneal and Appendiceal Malignancies
- Colorectal Cancer Treatments and Studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Colorectal Cancer Surgical Treatments
- Pancreatic and Hepatic Oncology Research
- Radiomics and Machine Learning in Medical Imaging
- Neuroendocrine Tumor Research Advances
Which keywords describe Grégoire Desolneux's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Survival Analysis, Chemotherapy, Hepatocellular Carcinoma, Liver Cancer, Precision Medicine, Cytoreductive Surgery and Intraperitoneal Chemotherapy.
- Neuroendocrine Tumors
- Radiomics
- Medical Imaging
- Preoperative Chemoradiotherapy
- Biliary Tract Cancer
- Cetuximab
- Intraperitoneal Chemotherapy
- Precision Medicine
- Hepatocellular Carcinoma
- Survival Analysis
- Clinical Practice Guidelines
- Chemotherapy
- Liver Cancer
- Cytoreductive Surgery
- Neoadjuvant Therapy
- KRAS Mutations
- Cholangiocarcinoma
- Rectal Cancer
- Pancreatic Cancer
- Surgical Complications
- Pancreatic Neuroendocrine Tumors
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Clinical Practice Guidelines232 topics
- Survival Analysis172 topics
- Chemotherapy162 topics
- Hepatocellular Carcinoma161 topic
- Liver Cancer161 topic
- Precision Medicine162 topics
- Cytoreductive Surgery131 topic
- Intraperitoneal Chemotherapy131 topic
- Neoadjuvant Therapy122 topics
- Cetuximab111 topic
- KRAS Mutations111 topic
- Biliary Tract Cancer81 topic
- Cholangiocarcinoma81 topic
- Preoperative Chemoradiotherapy71 topic
- Rectal Cancer71 topic
- Medical Imaging51 topic
- Pancreatic Cancer51 topic
- Radiomics51 topic
- Surgical Complications51 topic
- Neuroendocrine Tumors41 topic
- Pancreatic Neuroendocrine Tumors41 topic
Where does Grégoire Desolneux work?
Grégoire Desolneux's main affiliation in the publication record is Institut Bergonié, France.
How many publications and citations does Grégoire Desolneux have?
OpenAlex counts 48 works and 761 citations for Grégoire Desolneux, an h-index of 14, ranking #2,509,141 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Grégoire Desolneux. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.